1Department of Pathology, NYU Grossman School of Medicine, New York, New York.

1Department of Genetics, Yale University School of Medicine, New Haven, Connecticut.

1Department of Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ...

1Department of Urologic Surgery, University of California Davis, Davis, California.

You do not currently have access to this content.

AbstractWe performed whole-exome sequencing of 250 unique tumor tissues from 30 multi-region sampled pancreatic cancer research autopsies from patients diagnosed with advanced-stage disease.

To help defray the rising costs of initial manuscript screening and publication, the AACR journals levy fees as detailed herein. Authors are required to confirm at the time of submission that they ...

Abstract:. In updated phase I clinical trial results, patients treated with zoldonrasib, a KRASG12D-selective inhibitor under study in non–small cell lung cancer, showed an objective response rate of ...

Abstract:. In a phase I clinical trial, patients with oral precancers who received immunotherapy injected directly into their lesions experienced tumor shrinkage and no dose-limiting toxicities. The ...

Abstract:. According to a new study, exposure to smoke from wildfires is associated with lung, colorectal, breast, bladder, and blood cancers, highlighting the long-term health risks it poses.

Abstract:. Results from two separate phase I/II studies investigating the pan-RAS inhibitor daraxonrasib suggest it is safe and effective for patients with pancreatic ductal adenocarcinoma, building ...